Ticker Details
Nuvalent, Inc.
IPO Date:	July 29, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.07B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.29 | 2.84%
Avg Daily Range (30 D):	$1.50 | 1.46%
Avg Daily Range (90 D):	$1.62 | 1.57%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	.43M
Avg Daily Volume (90 D):	.44M

Trade Size
Avg Trade Size (Sh.):	48
Avg Trade Size (Sh.) (30 D):	44
Avg Trade Size (Sh.) (90 D):	45

Institutional Trades
Total Institutional Trades:	2,186
Avg Institutional Trade:	$3.41M
Avg Institutional Trade (30 D):	$5.03M
Avg Institutional Trade (90 D):	$4.92M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.27M
Avg Closing Trade (30 D):	$7.02M
Avg Closing Trade (90 D):	$7.24M
Avg Closing Volume:	72.89K

News

Apr 16, 2026 @ 5:00 PM Non-Small Cell Lung Cancer Clinical Trial Race Int... Source: Delveinsight

Mar 17, 2026 @ 12:00 AM This Investor Sold $104 Million of Nuvalent Stock ... Source: Jonathan Ponciano

Feb 23, 2026 @ 3:01 PM Biotech Fund Dumps $84 Million of Nuvalent With St... Source: Jonathan Ponciano

Dec 31, 2025 @ 3:47 PM What's Going On With Royalty Pharma Stock Wednesda... Source: Vandana Singh

Aug 7, 2025 @ 12:18 PM Nuvalent (NUVL) Q2 R&D Up 65% Source: Jesterai

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-6.06	$-1.39	$-1.58
Diluted EPS	$-6.06	$-1.39	$-1.58
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-450.07M	$-109.28M	$-118.71M
Operating Income / Loss	$-438.9M	$-119.41M	$-102.23M
Cost of Revenue
Net Cash Flow	$38.9M	$-102.01M	$145.99M
PE Ratio

Splits
Mar 10, 2017	1:1200000